LAUSR

Abstract The following study is considered as the first ethnobotanical survey in El Kantara's area; the gateway to the Algerian Sahara. The main objective of this survey is to document the indigenous knowledge and to highlight the floristic diversity of this region in order to establish a catalog of traditional medicinal plants used in phytotherapy and the food field, It is useful for subsequent pharmacological research. Ethnobotanical surveys were conducted for two years (2017–2019). The surveys collected sociodemographic data (age, sex, education level) and traditional knowledge on medicinal plants (vernacular name, part used, method of use). The data collected throughout the structured interview was analyzed by using quantitative indices in terms of the value of the use of the species (UV), informant consensus factor (ICF), and fidelity level (FL). A total of 95 informants reported 60 medicinal plants belonging to 29 botanical families of which 11 species have food usage. Asteraceae was the most common family (21.66%), followed by the Lamiaceae family (15%). Results of sociodemographic data showed the predominance of female sex with (64.21%), the majority of surveyed people are aged between 40 and 50 years old, while (67.37%) of the informants were illiterate. Artemisia herba-alba Asso was the most frequently used by the local population, with the highest UV of 1.26 (120 usage reports). The leaves were most used, while infusion was the most preferred form of use. New usage of 28 species was documented. Gastrointestinal system disorders and cardiovascular system diseases had the highest ICF (0.94) with 451 and 261 use reports respectively. The most common species Paronychia argentea Lam. was used for kidney disorders with a degree of fidelity of 100%. This study has highlighted the importance of traditional medicine in the El Kantara area and revealed a wealth of ethnobotanical knowledge in phytotherapy and the food sector. Findings should be subjects of further pharmacological and food studies to isolate bioactive compounds and validate their use.